8TOV
HIV-CA Disulfide linked Hexamer bound to Quinazolin-4-one Scaffold inhibitor
Summary for 8TOV
Entry DOI | 10.2210/pdb8tov/pdb |
Descriptor | Matrix protein p17, 2-[4-(4-aminobenzene-1-sulfonyl)-2-oxopiperazin-1-yl]-N-[(1R)-2-(3,5-difluorophenyl)-1-{3-[4-(morpholine-4-sulfonyl)phenyl]-4-oxo-3,4-dihydroquinazolin-2-yl}ethyl]acetamide (3 entities in total) |
Functional Keywords | hiv-1, human immunodeficiency virus, capsid, hiv-ca, capsid inhibitor, hiv restriction, viral protein |
Biological source | Human immunodeficiency virus 1 |
Total number of polymer chains | 12 |
Total formula weight | 315397.68 |
Authors | Goldstone, D.C.,Barnett, M.J.,Taka, J.R.H. (deposition date: 2023-08-04, release date: 2023-12-20, Last modification date: 2023-12-27) |
Primary citation | Xu, S.,Sun, L.,Barnett, M.,Zhang, X.,Ding, D.,Gattu, A.,Shi, D.,Taka, J.R.H.,Shen, W.,Jiang, X.,Cocklin, S.,De Clercq, E.,Pannecouque, C.,Goldstone, D.C.,Liu, X.,Dick, A.,Zhan, P. Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators. J.Med.Chem., 66:16303-16329, 2023 Cited by PubMed: 38054267DOI: 10.1021/acs.jmedchem.3c01647 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.7 Å) |
Structure validation
Download full validation report